The Use of Virtual Reality for the Treatment of Visual Vertigo.
NCT ID: NCT03020654
Last Updated: 2018-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
18 participants
INTERVENTIONAL
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The control group and treatment groups will be presented with two different sets of environments and be given the same head and eye exercises to complete within the environment. They will also be provided with at home exercises to complete.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Vestibular Training on Postural Control of Healthy Adults Using Virtual Reality
NCT05941039
Virtual Reality Compared to Other Forms of Optokinetic Stimulation in the Rehabilitation of Vestibular Syndromes.
NCT03838562
Concurrent Vestibular Activation and Postural Training Using Virtual Reality
NCT05942781
Virtual Reality in People With Persistent Postural-Perceptual Dizziness
NCT06366542
Dose of Vestibular Rehabilitation for Vestibular Hypofunction
NCT04851184
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment group
Virtual environment with fast moving objects these are graded in intensity from 1-7. Participants complete head and eye exercises within the environment using focus points such as benches and lanterns for a six week treatment program.
Virtual environment with fast moving objects
A beach/park environment with graded moving objects, the individual will complete head and eye exercises.
Control group
Virtual environment with no movement graded at grade 0. Participants complete head and eye exercises within the environment using focus points such as benches and lanterns for a six week treatment program.
Virtual environment with no movement
A beach/park environment with static objects, the individual will complete head and eye exercises.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual environment with fast moving objects
A beach/park environment with graded moving objects, the individual will complete head and eye exercises.
Virtual environment with no movement
A beach/park environment with static objects, the individual will complete head and eye exercises.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Those who have been determined to have no or limited balance function in both ears.
* Those with reduced visual acuity that will leave them unable to view the 3D effects of the head mounted display.
* Those with severe mental health disorders e.g. psychosis, paranoid disorders, bipolar disorder or a history of substance abuse.
* Severe neck pain/ restricted movement.
* Previous treatment for visual vertigo.
* Those with an fluctuating vestibular disorder such as Ménière's disease or vestibular migraine.
* Those with untreated Benign Paroxymal Positional Vertigo (BPPV).
* Those with a significant brain injury, or head injury that results in a central vestibular disorder.
* Those with an arrhythmia.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Manchester
OTHER
Sheffield Teaching Hospitals NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kirsty M Walker, BSc
Role: PRINCIPAL_INVESTIGATOR
Sheffield Teaching Hospitals NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Hallamshire Hospital
Sheffield, South Yorkshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5375
Identifier Type: OTHER
Identifier Source: secondary_id
STH19451
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.